Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

57.72
-1.6500-2.78%
Post-market: 57.62-0.1006-0.17%19:52 EDT
Volume:1.39M
Turnover:80.44M
Market Cap:5.58B
PE:-12.13
High:59.37
Open:58.22
Low:57.10
Close:59.37
52wk High:78.48
52wk Low:44.12
Shares:96.69M
Float Shares:93.17M
Volume Ratio:0.89
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7595
EPS(LYR):-6.4700
ROE:-26.09%
ROA:-14.20%
PB:3.20
PE(LYR):-8.92

Loading ...

CRISPR Therapeutics: Buy Rating Reiterated as Pediatric CASGEVY Label Expands; $80 Price Target Maintained

TIPRANKS
·
Jul 08

CRISPR Gene Editing Therapy Shows Groundbreaking Efficacy in Pediatric Patients

Deep News
·
Jun 30

HCA Healthcare announces research published in NEJM on CRISPR-based therapy

TIPRANKS
·
Jun 29

Week's Best: Spacex is Changing Market Indexes. ETF Investors, Take Note.

Dow Jones
·
Jun 27

Gil Blum Reiterates Buy on CRISPR Therapeutics, Maintains $82 Price Target on Pipeline Upside and 2026 Data Catalysts

TIPRANKS
·
Jun 24

Thanks to SpaceX, Index Funds Won't Track Each Other as Closely. Here's One Pro's Advice. -- Barrons.com

Dow Jones
·
Jun 23

Nutrien, CAVA, Cracker Barrel, ADMA, CRISPR Trending With Analysts

TIPRANKS
·
Jun 13

Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
Jun 11

Why CRISPR Therapeutics (CRSP) Is Down 7.7% After Major Shelf Filing and Governance Changes – And What's Next

Simply Wall St.
·
Jun 07

Shareholders Approve New Incentive Plan and Governance Measures

TIPRANKS
·
Jun 05

CRISPR Therapeutics shareholders approve 2026 stock option and incentive plan at annual meeting

Reuters
·
Jun 05

Analysts Are Bullish on Top Healthcare Stocks: Insulet (PODD), Crispr Therapeutics AG (CRSP)

TIPRANKS
·
Jun 04

Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026

GlobeNewswire
·
Jun 01

Why Intellia Therapeutics (NTLA) Is Up 10.6% After CRISPR Phase III Win And FDA Hold Lift

Simply Wall St.
·
May 29

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 28

Crispr Therapeutics Opens New Front in Cholesterol With CTX310 Trial

TIPRANKS
·
May 23

Analysts Are Bullish on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Caris Life Sciences, Inc. (CAI)

TIPRANKS
·
May 14

A Look At CRISPR Therapeutics (CRSP) Valuation As CASGEVY Progress And New Funding Lift Investor Interest

Simply Wall St.
·
May 12

Vertex Pharmaceuticals announces Casgevy reimbursement agreement

TIPRANKS
·
May 07

Analysts Conflicted on These Healthcare Names: Dexcom (DXCM), Ironwood Pharma (IRWD) and Crispr Therapeutics AG (CRSP)

TIPRANKS
·
May 06